Medplus Health Services Limited Share Price & Analysis
₹676.35+2.38%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹676.35+2.38%Open
₹661.10High
₹690.80Low
₹650.20Close
₹676.3552W High
₹1022.2052W Low
₹647.00Volume
311KLot Size
1Sector
Consumer ServicesMarket Cap
₹8K CrFace Value
₹2Mid Cap
Price Chart
Candle
Range
Fundamentals
P/E
38.60Sector P/E
52.90P/B
4.11EPS
₹17.54ROE
11.60%ROCE
12.60%D/E Ratio
0.72Div Yield
0.00%Book Value
₹165.00Strengths
- Attractively valued vs sector (P/E 38.6x vs industry 52.9x)
- Near 52-week low — potential value zone (₹647)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| ETERNAL ETERNAL LIMITED | ₹323 | ₹3.1L Cr | 719 | 10.05 | 0.38 | 2.48 | 0.11 |
| DMART Avenue Supermarts Limited | ₹3,770 | ₹2.5L Cr | 80.4 | 10.05 | 12.9 | 17.2 | 0.07 |
| TRENT Trent Limited | ₹2,853 | ₹1.5L Cr | 83.2 | 21.78 | 27.7 | 28.3 | 0.37 |
| LENSKART Lenskart Solutions Limited | ₹656 −0.58% | ₹1.2L Cr | 181 | 13.04 | 6.33 | 8.08 | 0.45 |
| INDHOTEL The Indian Hotels Company Limited | ₹720 | ₹1.0L Cr | 52.7 | 7.85 | 14.2 | 17.1 | 0.28 |
| MEESHO Meesho Limited | ₹206 +0.61% | ₹97K Cr | — | 21.47 | -46.2 | -40 | 0.01 |
| NYKAA FSN E-Commerce Ventures Limited | ₹333 | ₹95K Cr | 358 | 66.24 | 15.3 | 17.2 | 1.01 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
MEDPLUS · as of Mar 2026
Promoters40.33%0.06pp
FII15.61%0.38pp
DII26.19%0.53pp
Public17.82%0.86pp
Others0.05%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 40.45% | 40.39% | 40.39% | 40.39% | 40.39% | 40.33% |
| FII | 12.96% | 14.94% | 14.85% | 14.72% | 15.23% | 15.61% |
| DII | 25.19% | 22.47% | 22.17% | 27.98% | 25.66% | 26.19% |
| Public | 21.31% | 22.10% | 22.51% | 16.85% | 18.68% | 17.82% |
| Others | 0.10% | 0.10% | 0.08% | 0.07% | 0.05% | 0.05% |
Corporate Events
Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 ("SEBI LODR")
Board Mtg20 Jul 2026
Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR ")
Board Mtg28 May 2026
Revised Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR ")
Board Mtg19 May 2026
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.8K Cr 7.6% | ₹1.7K Cr 8.8% | ₹1.5K Cr 2.2% | ₹1.5K Cr 3.3% | ₹1.6K Cr 1.0% | ₹1.6K Cr 5.8% | ₹1.5K Cr 0.1% | ₹1.5K Cr |
| Op. Profit | ₹159 Cr 6.7% | ₹149 Cr 13.7% | ₹131 Cr 3.7% | ₹136 Cr 2.3% | ₹133 Cr 7.3% | ₹124 Cr 31.9% | ₹94 Cr 11.3% | ₹106 Cr |
| OPM | 9.0% 0.0% | 9.0% 12.5% | 8.0% 11.1% | 9.0% 12.5% | 8.0% 0.0% | 8.0% 33.3% | 6.0% 14.3% | 7.0% |
| Net Profit | ₹58 Cr 3.6% | ₹56 Cr 33.3% | ₹42 Cr 17.6% | ₹51 Cr 10.9% | ₹46 Cr 17.9% | ₹39 Cr 178.6% | ₹14 Cr 58.8% | ₹34 Cr |
| EPS (₹) | 4.82 4.1% | 4.63 30.8% | 3.54 17.5% | 4.29 12.0% | 3.83 18.2% | 3.24 170.0% | 1.2 57.0% | 2.79 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹6.9K Cr 12.3% | ₹6.1K Cr 9.1% | ₹5.6K Cr 23.4% | ₹4.6K Cr 20.6% | ₹3.8K Cr 23.1% | ₹3.1K Cr 6.9% | ₹2.9K Cr 26.3% | ₹2.3K Cr 6.7% | ₹2.1K Cr 6.0% | ₹2.0K Cr |
| Expenses | ₹6.3K Cr 11.3% | ₹5.6K Cr 7.2% | ₹5.3K Cr 22.8% | ₹4.3K Cr 22.4% | ₹3.5K Cr 23.0% | ₹2.9K Cr 4.2% | ₹2.7K Cr 27.1% | ₹2.2K Cr 3.9% | ₹2.1K Cr 6.9% | ₹1.9K Cr |
| Op. Profit | ₹608 Cr 24.6% | ₹488 Cr 37.5% | ₹355 Cr 33.5% | ₹266 Cr 2.6% | ₹273 Cr 25.8% | ₹217 Cr 61.9% | ₹134 Cr 11.7% | ₹120 Cr 106.9% | ₹58 Cr 18.3% | ₹71 Cr |
| OPM | 9.0% 12.5% | 8.0% 33.3% | 6.0% 0.0% | 6.0% 14.3% | 7.0% 0.0% | 7.0% 48.9% | 4.7% 6.0% | 5.0% 85.2% | 2.7% 32.5% | 4.0% |
| Other Income | ₹71 Cr 47.9% | ₹48 Cr 20.0% | ₹40 Cr 13.0% | ₹46 Cr 48.4% | ₹31 Cr 47.6% | ₹21 Cr 23.5% | ₹17 Cr 54.5% | ₹11 Cr 37.5% | ₹8 Cr 14.3% | ₹7 Cr |
| Interest | ₹120 Cr 16.5% | ₹103 Cr 7.3% | ₹96 Cr 15.7% | ₹83 Cr 25.8% | ₹66 Cr 20.0% | ₹55 Cr 17.0% | ₹47 Cr 6.0% | ₹50 Cr 78.6% | ₹28 Cr 47.4% | ₹19 Cr |
| Depreciation | ₹283 Cr 13.2% | ₹250 Cr 11.6% | ₹224 Cr 23.1% | ₹182 Cr 52.9% | ₹119 Cr 35.2% | ₹88 Cr 17.3% | ₹75 Cr 27.1% | ₹59 Cr 391.7% | ₹12 Cr 9.1% | ₹11 Cr |
| PBT | ₹275 Cr 50.3% | ₹183 Cr 150.7% | ₹73 Cr 55.3% | ₹47 Cr 60.2% | ₹118 Cr 24.2% | ₹95 Cr 227.6% | ₹29 Cr 26.1% | ₹23 Cr 11.5% | ₹26 Cr 45.8% | ₹48 Cr |
| Tax % | 20.0% 11.1% | 18.0% 63.6% | 11.0% 283.3% | -6.0% 130.0% | 20.0% 41.2% | 34.0% 63.8% | 94.0% 95.8% | 48.0% 173.8% | -65.0% 262.5% | 40.0% |
| Net Profit | ₹220 Cr 46.7% | ₹150 Cr 127.3% | ₹66 Cr 32.0% | ₹50 Cr 47.4% | ₹95 Cr 50.8% | ₹63 Cr 3050.0% | ₹2 Cr 83.3% | ₹12 Cr 71.4% | ₹42 Cr 44.8% | ₹29 Cr |
| EPS (₹) | 18.3 45.7% | 12.56 129.2% | 5.48 31.4% | 4.17 48.1% | 8.03 99.4% | 1,393.11 1201.7% | 107.02 81.7% | 585.46 71.9% | 2,080.06 28.4% | 1,620.57 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||||
| Equity Capital | ₹24 Cr 0.0% | ₹24 Cr 0.0% | ₹24 Cr 0.0% | ₹24 Cr 0.0% | ₹24 Cr 5233.3% | ₹0.45 Cr 136.8% | ₹0.19 Cr 0.0% | ₹0.19 Cr 0.0% | ₹0.19 Cr 11.8% | ₹0.17 Cr |
| Reserves | ₹1.8K Cr 6.1% | ₹1.7K Cr 10.5% | ₹1.6K Cr 5.9% | ₹1.5K Cr 5.2% | ₹1.4K Cr 91.0% | ₹730 Cr 38.3% | ₹528 Cr 81.4% | ₹291 Cr 4.0% | ₹303 Cr 104.7% | ₹148 Cr |
| Borrowings | ₹1.2K Cr 6.5% | ₹1.1K Cr 10.9% | ₹1.0K Cr 12.2% | ₹900 Cr 10.4% | ₹815 Cr 38.1% | ₹590 Cr 23.7% | ₹477 Cr 11.2% | ₹429 Cr 164.8% | ₹162 Cr 20.6% | ₹204 Cr |
| Other Liabilities | ₹534 Cr 6.8% | ₹500 Cr 19.9% | ₹417 Cr 2.7% | ₹406 Cr 12.5% | ₹361 Cr 47.3% | ₹245 Cr 28.8% | ₹344 Cr 43.9% | ₹239 Cr 33.5% | ₹179 Cr 2.2% | ₹183 Cr |
| Total Liabilities | ₹3.6K Cr 6.3% | ₹3.4K Cr 11.8% | ₹3.0K Cr 7.4% | ₹2.8K Cr 7.8% | ₹2.6K Cr 65.6% | ₹1.6K Cr 16.1% | ₹1.3K Cr 40.7% | ₹959 Cr 48.9% | ₹644 Cr 20.4% | ₹535 Cr |
Assets | ||||||||||
| Fixed Assets | ₹1.4K Cr 4.6% | ₹1.3K Cr 4.3% | ₹1.2K Cr 9.1% | ₹1.1K Cr 42.4% | ₹799 Cr 54.5% | ₹517 Cr 23.4% | ₹419 Cr 11.1% | ₹377 Cr 354.2% | ₹83 Cr 2.5% | ₹81 Cr |
| CWIP | ₹17 Cr 6.3% | ₹16 Cr 45.5% | ₹11 Cr 56.0% | ₹25 Cr 25.0% | ₹20 Cr 233.3% | ₹6 Cr 20.0% | ₹5 Cr 400.0% | ₹1 Cr 0.0% | ₹1 Cr 50.0% | ₹2 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹2.2K Cr 7.5% | ₹2.0K Cr 16.8% | ₹1.8K Cr 7.3% | ₹1.6K Cr 8.0% | ₹1.8K Cr 70.2% | ₹1.0K Cr 12.9% | ₹924 Cr 59.3% | ₹580 Cr 3.6% | ₹560 Cr 23.6% | ₹453 Cr |
| Total Assets | ₹3.6K Cr 6.3% | ₹3.4K Cr 11.8% | ₹3.0K Cr 7.4% | ₹2.8K Cr 7.8% | ₹2.6K Cr 65.6% | ₹1.6K Cr 16.1% | ₹1.3K Cr 40.7% | ₹959 Cr 48.9% | ₹644 Cr 20.4% | ₹535 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹540 Cr 275.0% | ₹144 Cr 60.0% | ₹90 Cr 47.1% | ₹170 Cr 5566.7% | ₹3 Cr 142.9% | ₹-7 Cr 104.8% | ₹147 Cr 359.4% | ₹32 Cr 5.9% | ₹34 Cr 300.0% | ₹-17 Cr |
| Investing CF | ₹-318 Cr 283.1% | ₹-83 Cr 119.3% | ₹429 Cr 161.0% | ₹-703 Cr 1908.6% | ₹-35 Cr 25.0% | ₹-28 Cr 47.4% | ₹-19 Cr 5.6% | ₹-18 Cr 20.0% | ₹-15 Cr 53.1% | ₹-32 Cr |
| Financing CF | ₹-228 Cr 15.2% | ₹-198 Cr 16.5% | ₹-170 Cr 138.6% | ₹440 Cr 7433.3% | ₹-6 Cr 106.7% | ₹90 Cr 208.4% | ₹-83 Cr 8200.0% | ₹-1 Cr 96.6% | ₹-29 Cr 182.9% | ₹35 Cr |
| Net Cash Flow | ₹-5 Cr 96.4% | ₹-137 Cr 139.1% | ₹350 Cr 476.3% | ₹-93 Cr 151.4% | ₹-37 Cr 166.1% | ₹56 Cr 24.4% | ₹45 Cr 221.4% | ₹14 Cr 240.0% | ₹-10 Cr 33.3% | ₹-15 Cr |
| Free Cash Flow | ₹482 Cr 690.2% | ₹61 Cr 178.2% | ₹-78 Cr 239.3% | ₹56 Cr 209.8% | ₹-51 Cr 37.8% | ₹-37 Cr 129.6% | ₹125 Cr 290.6% | ₹32 Cr 68.4% | ₹19 Cr 154.3% | ₹-35 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1d 0.0% | 1d 0.0% | 1d 0.0% | 1d 0.0% | 1d 0.0% | 1d 0.0% | 1d 50.0% | 2d | 0d 100.0% | 1d |
| Inventory Days | 106d 4.5% | 111d 5.1% | 117d 4.5% | 112d 0.9% | 113d 11.9% | 101d 29.5% | 78d 2.6% | 76d 0.0% | 76d 7.3% | 82d |
| Days Payable | 24d 14.3% | 21d 22.2% | 27d 10.0% | 30d 36.4% | 22d 40.5% | 37d 19.4% | 31d 14.8% | 27d 8.0% | 25d 13.8% | 29d |
| Cash Conv. Cycle | 83d 9.8% | 92d 1.1% | 91d 11.0% | 82d 9.9% | 91d 40.0% | 65d 35.4% | 48d 5.9% | 51d 0.0% | 51d 3.8% | 53d |
| Working Capital Days | 54d 6.9% | 58d 0.0% | 58d 42.0% | 100d 117.4% | 46d 84.0% | 25d 212.5% | 8d 38.5% | 13d 7.1% | 14d 16.7% | 12d |
| ROCE | 10.0% 42.9% | 7.0% 40.0% | 5.0% 50.0% | 10.0% 23.1% | 13.0% 44.4% | 9.0% 25.0% | 12.0% 7.7% | 13.0% 31.6% | 19.0% 72.7% | 11.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Medplus Health Services Limited share price today?
Medplus Health Services Limited (MEDPLUS) is currently trading at ₹676.35 on NSE, up 2.38% as of the last market session. Prices update daily after market close on MarketNetra.
Is Medplus Health Services Limited available in F&O (Futures & Options)?
Yes, Medplus Health Services Limited (MEDPLUS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Medplus Health Services Limited 52-week high and low?
Medplus Health Services Limited's 52-week high is ₹1,022.2 and the 52-week low is ₹647. The current price of ₹676.35 is 33.8% below the 52W high.
What is Medplus Health Services Limited P/E ratio?
Medplus Health Services Limited's current P/E ratio is 38.6. This indicates the market is paying ₹38.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Medplus Health Services Limited options?
Medplus Health Services Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade MEDPLUS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.